Influence of body mass index on the choice of therapy for depression and follow-up care

Obesity

Volumn 21, Issue 3, 2013, Pages

  Boudreau, Denise M ^a   Arterburn, David ^a   Bogart, Andy ^a   Haneuse, Sebastien ^b   Theis, Mary Kay ^a   Westbrook, Emily ^a   Simon, Greg ^c  

^a CENTER FOR HEALTH STUDIES   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE; TRAZODONE;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT DECISION MAKING; PSYCHOTHERAPY; SMOKING; TREATMENT DURATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BODY MASS INDEX; CHOICE BEHAVIOR; COHORT STUDIES; DEPRESSION; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIANSERIN; MIDDLE AGED; OBESITY; PAROXETINE; PSYCHOTHERAPY; YOUNG ADULT;

EID: 84876474371     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20048     Document Type: Article

References (40)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
2. Stunkard AJ, Faith MS, Allison KC,. Depression and obesity. Biol Psychiatry 2003; 54: 330-337.
3. Faith MS, Matz PE, Jorge MA,. Obesity-depression associations in the population. J Psychosom Res 2002; 53: 935-942.
4. Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW,. Is obesity associated with major depression? Results from the third national health and nutrition examination survey. Am J Epidemiol 2003; 158: 1139-1147.
5. Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS,. Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: national health and nutrition examination survey 2005-2006. BMC Psychiatry 2011; 11: 130.
6. Heo M, Pietrobelli A, Fontaine KR, Sirey JA, Faith MS,. Depressive mood and obesity in US adults: comparison and moderation by sex, age, and race. Int J Obes 2006; 30: 513-519.
7. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229.
8. Faith MS, Butryn M, Wadden TA, Fabricatore A, Nguyen AM, Heymsfield SB,. Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev 2011; 12: e438-e453.
9. Patten SB, Williams JV, Lavorato DH, Khaled S, Bulloch AG,. Weight gain in relation to major depression and antidepressant medication use. J Affect Disord 2011; 134: 288-293.
10. Goodman E, Whitaker RC,. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002; 110: 497-504.
11. Patten SB, Williams JV, Lavorato DH, Brown L, McLaren L, Eliasziw M,. Major depression, antidepressant medication and the risk of obesity. Psychother Psychosom 2009; 78: 182-186.
12. Hach I, Ruhl UE, Klotsche J, Klose M, Jacobi F,. Associations between waist circumference and depressive disorders. J Affect Disord 2006; 92: 305-308.
13. Ho RC, Niti M, Kua EH, Ng TP,. Body mass index, waist circumference, waist-hip ratio and depressive symptoms in Chinese elderly: a population-based study. Int J Geriatr Psychiatry 2008; 23: 401-408.
14. Simon GE, Rohde P, Ludman EJ, et al. Association between change in depression and change in weight among women enrolled in weight loss treatment. Gen Hosp Psychiatry 2010; 32: 583-589.
15. Wing RR, Epstein LH, Marcus MD, Kupfer DJ,. Mood changes in behavioral weight loss programs. J Psychosom Res 1984; 28: 189-196.
16. Wadden TA, Foster GD, Letizia KA,. One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consult Clin Psychol 1994; 62: 165-171.
17. Schowalter M, Benecke A, Lager C, et al. Changes in depression following gastric banding: a 5- to 7-year prospective study. Obes Surg 2008; 18: 314-320.
18. Ricca V, Mannucci E, Di Bernardo M, Rizzello SM, Cabras PL, Rotella CM,. Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients. J Endocrinol Invest 1996; 19: 727-733.
19. Serretti A, Mandelli L,. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010; 71: 1259-1272.
20. Aronne LJ, Segal KR,. Weight gain in the treatment of mood disorders. J Clin Psychiatry 2003; 64 (Suppl 8): 22-29.
21. Berkowitz RI, Fabricatore AN,. Obesity, psychiatric status, and psychiatric medications. Psychiatr Clin North Am 2005; 28: 39-54, vii-viii.
22. Deshmukh R, Franco K,. Managing weight gain as a side effect of antidepressant therapy. Cleve Clin J Med 2003; 70: 614, 616, 618, passim.
23. Kachur SG, Hannan CL, Ward KE,. Antidepressant-induced weight gain. Med Health R I 2005; 88: 359-361.
24. Schwartz TL, Nihalani N, Jindal S, Virk S, Jones N,. Psychiatric medication-induced obesity: a review. Obes Rev 2004; 5: 115-121.
25. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM,. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
26. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL,. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998; 22: 39-47.
27. Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D,. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 2007; 16: 560-570.
28. Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 2006; 30: 1585-1594.
29. Ludman EJ, Ichikawa LE, Simon GE, et al. Breast and cervical cancer screening specific effects of depression and obesity. Am J Prev Med 2010; 38: 303-310.
30. Bertakis KD, Azari R,. The impact of obesity on primary care visits. Obes Res 2005; 13: 1615-1623.
31. Saunders KDR, Stergachis A,. Group health cooperative. In: Pharmacoepidemiology., Strom BL, ed.; West Sussez, England: Wiley; 2005. pp 223-239.
32. Arterburn DE, Ichikawa L, Ludman E, et al. Validity of clinical body weight measures as substitutes for missing data in a randomized trial. Obes Res Clin Pract 2008; 2: 277-281.
33. Anderson B,. HEDIS antidepressant medication management measures and performance-based measures: an opportunity for improvement in depression care. Am J Manag Care 2007; 13: S98-S102.
34. Zeger SL, Liang KY, Albert PS,. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44: 1049-1060.
35. Hastie TJ,. Generalized additive models. In: Statistical Models., Chambers JM, Hastie TJ, eds.; Yonkers, NY: At&T Bell Laboratories; 1992. pp 249-308.
36. Diggle P, Heagerty P, Liang K, Zeger SL,. Analysis of Longitudinal Data, 2nd ed. Oxford: Oxford University Press; 2002.
37. Agresti A,. Analysis of Ordinal Categorical Data. Hoboken, NJ: Wiley; 1984.
38. Kuss O, McLerran D,. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 2007; 87: 262-269.
39. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 2011; 155: 772-785.
40. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004; 25: 119-142.